UroGen Pharma Ltd. (URGN)
43.25
-0.70
(-1.59%)
USD |
NASDAQ |
Sep 18, 16:00
43.30
+0.05
(+0.12%)
After-Hours: 20:00
UroGen Pharma Free Cash Flow : -170.67M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -170.67M |
| March 31, 2026 | -175.90M |
| December 31, 2025 | -172.59M |
| September 30, 2025 | -144.04M |
| June 30, 2025 | -124.30M |
| March 31, 2025 | -107.38M |
| December 31, 2024 | -97.05M |
| September 30, 2024 | -95.11M |
| June 30, 2024 | -83.61M |
| March 31, 2024 | -79.79M |
| December 31, 2023 | -73.89M |
| September 30, 2023 | -82.36M |
| June 30, 2023 | -82.75M |
| March 31, 2023 | -86.36M |
| December 31, 2022 | -84.55M |
| September 30, 2022 | -85.95M |
| June 30, 2022 | -88.12M |
| Date | Value |
|---|---|
| March 31, 2022 | -84.04M |
| December 31, 2021 | -87.71M |
| September 30, 2021 | -89.20M |
| June 30, 2021 | -97.47M |
| March 31, 2021 | -102.49M |
| December 31, 2020 | -110.53M |
| September 30, 2020 | -113.77M |
| June 30, 2020 | -99.82M |
| March 31, 2020 | -90.52M |
| December 31, 2019 | -72.77M |
| September 30, 2019 | -55.94M |
| June 30, 2019 | -51.89M |
| March 31, 2019 | -45.06M |
| December 31, 2018 | -36.78M |
| September 30, 2018 | -33.34M |
| June 30, 2018 | -21.34M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Xencor, Inc. | -208.28M |
| MeiraGTx Holdings Plc | 10.06M |
| Insmed, Inc. | -837.67M |
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| Viking Therapeutics, Inc. | -418.44M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -35.02M |
| Cash from Investing (Quarterly) | 1.185M |
| Cash from Financing (Quarterly) | 2.186M |
| Free Cash Flow Per Share (Quarterly) | -0.6963 |
| Free Cash Flow to Equity (Quarterly) | -34.11M |
| Free Cash Flow to Firm (Quarterly) | -19.56M |
| Free Cash Flow Yield | -8.01% |